AN UNBIASED VIEW OF TARLOX-TKI

The phylogenetic map in the human kinome demonstrating enhancement and US FDA acceptance of little molecule kinase inhibitors to tyrosine kinases and serine/threonine kinases for a range of solid and hematologic malignancies.The spectacular effects shown with imatinib mesylate (aka Gleevec) targeting split issue cluster (Bcr)-Abelson (Abl) fusion p